Cancer Strikes Again — Tennis Icon Exits Wimbledon

When Chris Evert said her cancer was back again, she did more than cancel Wimbledon; she forced the world to face what “relentless” really looks like.

Story Snapshot

Chris Evert, 71, has announced a third ovarian cancer recurrence and will miss Wimbledon.
She discovered the return after routine CT and PET scans and has already had surgery.^[1]
Evert carries a BRCA1 gene mutation and has battled ovarian cancer since 2021.^[5]
Her public honesty spotlights early detection and the gaps in how media covers cancer.^[13]

A champion faces a third round and steps away from Wimbledon

Chris Evert told fans her ovarian cancer has returned, for the third time in five years. She shared the news on Instagram, explaining that recent CT and PET scans raised new concerns.

She has already undergone surgery as the first step in this next fight and plans to begin chemotherapy in the coming weeks. Because of this, she will miss Wimbledon and step back from her work as an analyst to focus on her health.^[1]^[7]

Tennis legend Chris Evert says ovarian cancer has returned, will skip Wimbledon https://t.co/zCB5VvHCWK

— Action News on 6abc (@6abc) June 25, 2026

Evert’s decision to step away from one of tennis’s biggest stages shows how cancer cuts across status and success. You can be an 18-time Grand Slam singles champion and still have your calendar wiped out by one scan.

For many readers who race from meeting to meeting, this kind of pause feels unimaginable until a doctor forces it. Her announcement is not just about illness; it is about a hard reset of priorities that many people avoid until it is too late.^[1]

From family tragedy to genetic discovery and first diagnosis

This third recurrence sits atop a heavy backstory. Evert’s sister Jeanne died of ovarian cancer in 2020. That loss pushed Chris to get genetic testing, which revealed she carried a dangerous BRCA1 gene mutation tied to hereditary ovarian and breast cancers.

In December 2021, surgeons found stage 1 ovarian cancer during a hysterectomy and removed her ovaries and fallopian tubes. She then went through another surgery and six rounds of chemotherapy, finishing treatment in 2022.^[2]^[5]

Doctors told Evert her odds of full recovery were strong because the cancer was caught early. That early detection message should ring loud for anyone who thinks routine tests are optional.

For conservatives who value personal responsibility, this is a clear example: she did not wait for symptoms; she acted after her sister’s death and lived with the results, good and bad.

The hard truth is that many families only discover their genetic risks after someone dies. Evert’s case argues for facing those risks sooner, even when it is uncomfortable.^[5]

Recurrence, routine scans, and a relentless disease

Evert’s story shows how cancer can come back even after clean scans and hopeful headlines. She had a recurrence in 2023, when imaging revealed cancer cells in her pelvic region, leading to robotic surgery and more chemotherapy.

After that, she reached remission again in 2024. To watch for further trouble, her medical team scheduled routine CT and PET scans every three months. It was that ongoing surveillance that picked up the latest signs and led to her June 2026 surgery.^[1]^[2]^[4]^[7]

People often hear “cancer-free” and think the story is over. In reality, for many patients it becomes a chronic battle. Evert’s willingness to keep doing scans, and to talk about them, runs against the natural urge to look away.

That habit of regular checks aligns with common-sense values: you maintain your car before it breaks down; you should treat your own body with at least that level of care. Her case shows that vigilance does not guarantee safety, but it can catch danger earlier.

Social media honesty and what the cameras leave out

Evert chose to break the news on social media, as many public figures now do. When celebrities share cancer stories online, public attention and web searches about that cancer jump sharply, sometimes more than threefold.

That surge creates a window for people to learn about screening and symptoms they might otherwise ignore. In that sense, Evert’s post does more than update fans; it pushes ovarian cancer awareness back into the spotlight at a time when many still know very little about it.^[1]^[4]^[12]^[17]

Tennis Hall of Famer Chris Evert says she will miss Wimbledon after recurrence of ovarian cancer https://t.co/MMbPMuHATU

— Channel 3 News (@wcax) June 28, 2026

Research shows that media coverage of celebrity cancer often leaves out crucial medical detail and education. Stories focus on emotion and drama but skip basics like stage, treatment options, or prognosis. Evert has shared more than most, yet the public still lacks her exact pathology reports or full treatment plan.

People deserve clear information, not just sympathy. Her openness is a strong start, but doctors, journalists, and advocates should use moments like this to teach, not just to trend.^[13]